Trial intelligence / Profile preview

Dexmedetomidine vs magnesium sulphate for hemodynamic control during laparoscopic cholecystectomy

IRCT2017092136312N1Phase 2Completed

Sponsor
Golestan University of Medical Sciences
Start
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in cholelithiasis comparing Dexmedetomidine arm with Magnesium sulphate arm (2 arms). Primary endpoint: Hemodynamic changes during laparoscopic cholecystectomy. Started Oct 2017; status: completed.

02

Drugs

dexmedetomidinemagnesium sulfate
03

Conditions

cholelithiasis

Beyond the preview

Go deeper on IRCT2017092136312N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017092136312N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call